Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP438752.RAXRcI92mMMLoqNJk7MGpsqs7-XoHGEmrg9WoRYqzlTq0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP438752.RAXRcI92mMMLoqNJk7MGpsqs7-XoHGEmrg9WoRYqzlTq0130_assertion type Assertion NP438752.RAXRcI92mMMLoqNJk7MGpsqs7-XoHGEmrg9WoRYqzlTq0130_head.
- NP438752.RAXRcI92mMMLoqNJk7MGpsqs7-XoHGEmrg9WoRYqzlTq0130_assertion description "[Classification of SM patients into indolent (SM), aggressive SM (ASM), SM associated with a clonal non-MC lineage disease (SM-AHNMD), and mast cell leukemia (MCL) subgroups is a useful first step in establishing prognosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP438752.RAXRcI92mMMLoqNJk7MGpsqs7-XoHGEmrg9WoRYqzlTq0130_provenance.
- NP438752.RAXRcI92mMMLoqNJk7MGpsqs7-XoHGEmrg9WoRYqzlTq0130_assertion evidence source_evidence_literature NP438752.RAXRcI92mMMLoqNJk7MGpsqs7-XoHGEmrg9WoRYqzlTq0130_provenance.
- NP438752.RAXRcI92mMMLoqNJk7MGpsqs7-XoHGEmrg9WoRYqzlTq0130_assertion SIO_000772 21442641 NP438752.RAXRcI92mMMLoqNJk7MGpsqs7-XoHGEmrg9WoRYqzlTq0130_provenance.
- NP438752.RAXRcI92mMMLoqNJk7MGpsqs7-XoHGEmrg9WoRYqzlTq0130_assertion wasDerivedFrom befree-20140225 NP438752.RAXRcI92mMMLoqNJk7MGpsqs7-XoHGEmrg9WoRYqzlTq0130_provenance.
- NP438752.RAXRcI92mMMLoqNJk7MGpsqs7-XoHGEmrg9WoRYqzlTq0130_assertion wasGeneratedBy ECO_0000203 NP438752.RAXRcI92mMMLoqNJk7MGpsqs7-XoHGEmrg9WoRYqzlTq0130_provenance.